The evidence field · updated daily

5,395 peptide studies,
read so you don't have to.

Every randomized trial, cohort, review and preclinical paper on the peptides people actually use — pulled from PubMed, ClinicalTrials.gov, EuropePMC and PubChem, distilled into a plain-English digest, tagged by evidence strength, and laid out below as a living map of the field.

  1. 2026-06-23 PubMed

    ApoE Mimetics Enhance Drug Delivery Across Blood-Brain Barrier for Neurodegenerative and Cardiovascular Diseases

    This review underscores a pivotal shift in overcoming the **Blood-Brain Barrier**, a long-standing bottleneck in treating **neurodegenerative** and **cardiovascular diseases**. For peptide users and biohackers, understanding **ApoE mimet…

  2. 2026-06-23 PubMed

    Microglia activation and priming in neurodegenerative diseases reveal peptide, RNA, and inhibitor therapeutic targets

    This review significantly advances our understanding of **neurodegenerative diseases (NDDs)** by underscoring the central role of microglial activation and priming in disease pathogenesis. For clinicians and researchers, it identifies a …

  3. 2026-06-23 PubMed

    Morin treatment modulates MAPK/Nrf2/STAT-3 pathways, improving viability in H. pylori-infected gastric cells

    **Morin emerges as a promising natural compound for mitigating H. pylori-induced gastric damage**, potentially serving as a complementary therapeutic strategy. By modulating critical pathways like `MAPK`, `Nrf2`, and `STAT3`, morin could…

  4. 2026-06-23 PubMed

    2-Pyrazoline-5-one Derivative Suppresses Proliferation and Induces Apoptosis in Luminal A and Triple-Negative Breast Cancer Cells

    This study identifies a novel **2-pyrazoline-5-one derivative** with promising anticancer activity against difficult-to-treat **luminal A** and **triple-negative breast cancer** cells. The compound's ability to induce apoptosis, inhibit …

  5. 2026-06-23 PubMed

    Vunakizumab effectively treats moderate-to-severe plaque psoriasis across diverse baseline disease features

    This analysis provides crucial evidence that **vunakizumab** offers consistent and broad efficacy for patients with **moderate-to-severe plaque psoriasis**, irrespective of their specific baseline disease characteristics. This finding is…

  6. 2026-06-23 PubMed

    Senescent macrophages drive squamous cell carcinoma invasion via glutamine metabolism and IL-1β/NF-κB signaling

    Targeting the metabolic vulnerabilities of the **TME** represents a promising strategy for **SCC** treatment. This research uncovers a novel mechanism where senescent macrophages, driven by oxidative stress, hijack glutamine metabolism t…

  7. 2026-06-23 PubMed

    JN.1 mRNA vaccine boosts humoral and cellular immunity against SARS-CoV-2 variants, enhancing protection.

    JN.1 mRNA vaccine significantly boosted spike-specific T-cell frequencies and neutralizing antibody titers against SARS-CoV-2 variants.

  8. 2026-06-23 PubMed

    Peripheral blood T-cell subsets and tumor markers predict immunotherapy efficacy in advanced cervical cancer

    These findings suggest that **peripheral blood biomarkers offer a minimally invasive approach to predict and monitor immunotherapy response in advanced cervical cancer**. For clinicians, this could enable earlier identification of patien…

  9. 2026-06-23 PubMed

    BASP1 drives breast cancer progression and immunosuppression by recruiting MDSCs and suppressing T cells

    This research identifies **BASP1 as a critical dual-action target in breast cancer**, influencing both tumor cell behavior and the immunosuppressive tumor microenvironment. Understanding how **BASP1** promotes MDSC recruitment and suppre…

  10. 2026-06-23 PubMed

    Baicalin ameliorates acute pancreatitis by inhibiting cGAS/STING pathway activation in vivo and in vitro

    This study identifies the `cGAS/STING` pathway as a critical mediator in **acute pancreatitis** and positions baicalin as a potential therapeutic agent by targeting this pathway. **This suggests baicalin could offer a novel, mechanism-ba…

  11. 2026-06-23 PubMed

    Salvinorin A Alleviates Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization and MMT

    This study provides compelling preclinical evidence that **Salvinorin A** could be a novel therapeutic agent for pulmonary fibrosis, addressing a critical gap in current treatment options. By dually targeting M2 macrophage polarization a…

  12. 2026-06-23 PubMed

    Amino Acid-Functionalized Gold Nanochaperones Offer Strategic Roadmap for Alzheimer's Protein Misfolding Modulation

    This review provides a crucial framework for designing next-generation therapeutics targeting **protein misfolding** in **Alzheimer's disease**. **Understanding the specific amino acid-AuNP interactions with Aβ species is key to developi…

  13. 2026-06-23 PubMed

    Moringa oleifera defense peptides competitively inhibit human neutrophil elastase, offering novel anti-inflammatory scaffolds

    This research presents a **scalable and rapid workflow for identifying novel anti-inflammatory agents** from natural sources, which could significantly accelerate drug discovery. For biohackers and clinicians, this opens the door to expl…

  14. 2026-06-23 PubMed

    Hydroxyurea, BCL11A, and HBS1L-MYB gene variants interact to modulate fetal hemoglobin in Sickle Cell Anemia.

    Hydroxyurea, sex, and specific `BCL11A`/`HBS1L-MYB` gene variants significantly modulate fetal hemoglobin in **43** **sickle cell anemia** patients, explaining **46.5%** of variability.

  15. 2026-06-23 PubMed

    Humanin mitigates Aβ-induced RPE injury in AMD models via AMPK-Beclin1-dependent mitophagy activation

    This research highlights **Humanin** as a potential therapeutic agent for **Age-related macular degeneration (AMD)** by directly addressing **mitochondrial dysfunction** in the **RPE**. **Targeting mitophagy** with **Humanin** offers a n…

  16. 2026-06-23 PubMed

    Adjunctive GLP-1 RAs improve short-term weight loss after bariatric surgery, but not at 12 months

    This meta-analysis suggests that **adjunctive GLP-1 RA therapy can provide a short-term boost to weight loss outcomes after bariatric surgery**, particularly within the first 6 months. For individuals experiencing suboptimal initial weig…

  17. 2026-06-23 PubMed

    Semaglutide significantly lowers MACCE risk in obese T2DM patients with comorbid rheumatoid arthritis

    **Semaglutide offers significant primary cardiovascular protection** for a particularly high-risk population: obese individuals with **Type 2 Diabetes Mellitus** and **Rheumatoid Arthritis**. This real-world evidence expands the known be…

  18. 2026-06-23 PubMed

    Tirzepatide users in SURMOUNT-J maintained eating habits but struggled with exercise post-trial

    This study highlights the critical need for sustained support and therapeutic options for individuals managing **obesity disease** beyond the duration of a clinical trial. The strong desire of **75.9%** of participants to continue **tirz…

  19. 2026-06-23 PubMed

    Functional Hydrogels, including RADA16, Offer Advanced Solutions for Complex Nasal Wound Healing

    This comprehensive review underscores that **advanced functional hydrogels could revolutionize nasal wound care**, moving beyond passive packing to active, responsive biomaterials. By addressing the unique challenges of the nasal cavity,…

  20. 2026-06-23 PubMed

    Cellular Prion Protein and its Peptides: Multifaceted Roles in Neurodegeneration and Emerging Biomarker Potential

    The recognition of `PrPC` and its derived peptides as pleiotropic modulators opens new avenues for therapeutic intervention in **neurodegenerative diseases**. **Targeting `PrPC`'s processing or utilizing its neuroprotective fragments cou…

  21. 2026-06-23 PubMed

    225Ac/177Lu-DOTATATE PRRT achieves 85.7% 6-month progression-free survival in advanced meningiomas

    This pilot study offers a **promising new therapeutic avenue for patients with advanced, refractory meningiomas**, a condition with severely limited treatment options. The high `PFS-6` rate and favorable safety profile suggest that combi…

  22. 2026-06-23 PubMed

    Circulating IGF-1 levels show complex, non-linear associations with 27 digestive diseases in a large UK Biobank cohort

    This extensive prospective analysis provides unprecedented clarity on the complex, non-linear relationship between circulating **IGF-1** levels and a wide array of **digestive diseases**. **The key takeaway for clinicians and biohackers …

  23. 2026-06-23 PubMed

    Systematic Review Links Oxytocin Dysfunction to Severe Mental Illnesses After Childhood Adversity

    This systematic review strengthens the evidence for **oxytocin** as a critical neurobiological link between adverse childhood experiences and severe mental illnesses. For clinicians and researchers, this means **OXT** could serve as a va…

  24. 2026-06-23 PubMed

    Glaucoma Neuroprotection Review Highlights Nicotinamide, GLP-1RAs, and Advanced Translational Strategies

    This review provides a critical roadmap for developing the first clinically validated neuroprotective treatments for **glaucoma**, moving beyond sole reliance on IOP reduction. **It highlights specific agents like nicotinamide and GLP-1R…

  25. 2026-06-23 ClinicalTrials.gov

    Mecasermin (IGF-1) trial to evaluate safety and efficacy in post-heart attack patients

    If successful, this trial could establish **mecasermin** as a critical adjunctive therapy for **heart attack patients**, potentially altering the trajectory of **post-infarction heart failure**. Currently, interventions primarily focus o…

  26. 2026-06-23 ClinicalTrials.gov

    IGF-I injection into patellar tendons aims to boost collagen synthesis and improve structure

    While specific results are not available, this study's design highlights a critical area of research for **chronic patellar tendinopathy**. If `IGF-I` proves effective in stimulating collagen synthesis and improving tendon structure, it …

  27. 2026-06-23 ClinicalTrials.gov

    Post-discharge nutrition strategies compared for long-term growth, allergy, and metabolic risks in preterm children

    Understanding the long-term effects of post-discharge nutrition is crucial for **optimizing care protocols for preterm infants**. The findings from this study could provide evidence-based guidance for clinicians and parents on the most b…

  28. 2019-07-01 ClinicalTrials.gov

    Suvorexant pilot trial aims to improve sleep, reduce craving, and normalize HPA axis in substance use disorder patients

    If the aims of this pilot trial are met, **Suvorexant** could emerge as a valuable adjunctive therapy for **substance use disorder (SUD)** patients struggling with insomnia and craving. **Improving sleep quality and reducing craving** co…

  29. 2023-07-06 ClinicalTrials.gov

    Non-Invasive C-Tactile Stimulation Investigated for Chronic Osteoarthritis Pain Relief

    If proven effective, **non-invasive C-tactile stimulation** could offer a significant, drug-free alternative or adjunct therapy for individuals suffering from **chronic osteoarthritis pain**. This approach leverages the body's natural pa…

  30. 2026-06-23 ClinicalTrials.gov

    Intranasal oxytocin aims to improve social cognition and reduce opioid craving in methadone maintenance patients

    A study investigates if intranasal oxytocin can improve social cognition, reduce opioid craving, and shift implicit preferences in patients receiving methadone maintenance treatment.

  31. 2026-06-23 ClinicalTrials.gov

    Intravenous Oxytocin Investigated for Faster Post-Total Hip Arthroplasty Recovery, Measuring Daily Steps

    If successful, this research could introduce a novel therapeutic approach to accelerate recovery after **Total Hip Arthroplasty**, potentially reducing hospital stays and improving patient quality of life. **A positive outcome would sugg…

  32. 2026-06-23 ClinicalTrials.gov

    Short-term meditation intervention aims to improve health, mood, and cellular stress markers

    An exploratory pilot study investigates if short-term meditation can enhance health, mood, and reduce cellular stress and aging markers in meditators vs. controls.

  33. 2016-12-27 ClinicalTrials.gov

    Intranasal Oxytocin's Role in Belief Updating Under Stress Investigated in Randomized Trial

    Understanding how **intranasal oxytocin** influences **belief updating** under **stress** holds significant implications for both clinical practice and personal well-being. If oxytocin is found to enhance cognitive flexibility or mitigat…

  34. 2026-06-23 ClinicalTrials.gov

    Oxytocin and Cervical Balloon Combination for Labor Induction Study Terminated Early, Yielding No Efficacy Data

    Optimizing **labor induction** methods, particularly for women with an **unfavorable cervix**, remains a critical area in obstetrics. Reducing **cesarean section** rates while ensuring maternal and fetal safety is a key goal. While this …

  35. 2026-06-23 ClinicalTrials.gov

    Foley Catheter Addition to Oxytocin Investigated to Shorten Labor Induction Time in Term Membrane Rupture

    A study is investigating if adding a Foley catheter to oxytocin induction reduces time to delivery for women with term/near-term membrane rupture.

  36. 2019-11-14 ClinicalTrials.gov

    Erinacine A-enriched Hericium Erinaceus chocolate to augment antidepressant efficacy in major depressive disorder patients

    If successful, this study could **establish a novel, accessible adjunctive therapy for major depressive disorder**, potentially improving treatment response rates and patient quality of life. For individuals using antidepressants, incorp…

  37. 2026-06-23 ClinicalTrials.gov

    Randomized trial investigates Mazdutide's efficacy for prediabetes reversal in Chinese adults

    If successful, this trial could establish **Mazdutide** as a novel and effective pharmacological strategy for **prediabetes reversal**, offering a significant advancement beyond current lifestyle-focused interventions. For individuals wi…

  38. 2026-05-25 ClinicalTrials.gov

    Mazdutide trial to assess coronary plaque progression in overweight/obese patients with atherosclerosis

    If successful, this trial could establish **mazdutide** as a novel therapeutic strategy for directly mitigating **coronary atherosclerosis** progression in patients with **overweight** or **obesity**, beyond its known weight loss benefit…

  39. 2026-06-23 ClinicalTrials.gov

    Liraglutide and insulin detemir combination therapy to be investigated for myocardial glucose uptake in T2D

    This study aims to clarify how **liraglutide** and **insulin detemir** interact to influence **myocardial glucose uptake** in T2D patients. If synergy is demonstrated, it could lead to **optimized combination therapies** for improving ca…

  40. 2021-11-30 ClinicalTrials.gov

    XW003 GLP-1 analogue reduces body weight in obese adults, compares to liraglutide.

    XW003, a novel GLP-1 analogue, was evaluated against liraglutide for body weight reduction in obese adults, demonstrating its efficacy.

  41. 2019-03-07 ClinicalTrials.gov

    Liraglutide treatment for bile acid malabsorption compared against colesevelam

    If **Liraglutide** proves superior or offers a viable alternative to existing treatments like colesevelam for **bile acid malabsorption**, it could significantly **expand therapeutic options for patients suffering from chronic diarrhea**…

  42. 2016-03-14 ClinicalTrials.gov

    Liraglutide safety, tolerability, pharmacokinetics, and pharmacodynamics assessed in obese children aged 7-11 years

    A Phase 1 trial aims to evaluate liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in obese children aged 7-11.

  43. 2026-06-23 ClinicalTrials.gov

    Planned study to test liraglutide's effect on cognitive function in HIV-associated neurocognitive disorder

    Liraglutide will be tested for its effects on cognitive function in HIV-infected, overweight/obese T2DM patients.

  44. 2025-06-20 ClinicalTrials.gov

    CKD-bioMatch Trial Aims to Optimize Chronic Kidney Disease Treatment via Biomarker-Guided Therapy

    The CKD-bioMatch study will evaluate a biomarker-targeted treatment approach against standard of care to reduce **eGFR** decline in **CKD** patients with albuminuria.

  45. 2020-02-23 ClinicalTrials.gov

    Flexible Semaglutide Titration Regimen Proposed to Mitigate GI Adverse Events in Type 2 Diabetes

    This planned trial is highly relevant for **optimizing semaglutide treatment protocols** and improving patient experience. If a 16-week flexible titration significantly reduces GI-AEs, it could lead to updated clinical guidelines, making…

  46. 2026-04-01 ClinicalTrials.gov

    Semaglutide and Loxenatide Trial Aims to Improve Cardiac Autonomic Neuropathy in Type 2 Diabetes

    If successful, this trial could fundamentally shift the management of **diabetic cardiac autonomic neuropathy (DCAN)**, offering a targeted therapeutic strategy beyond general glycemic control. **For peptide users and clinicians, a posit…

  47. 2019-12-16 ClinicalTrials.gov

    Semaglutide Bioequivalence Study Compares Two Formulations in Different Pen-injectors for Overweight or Obesity

    **Establishing bioequivalence** for different semaglutide formulations and delivery devices is crucial for expanding access and flexibility in **obesity** management. If successful, this study could pave the way for new `pen-injector` de…

  48. 2026-06-16 ClinicalTrials.gov

    Tirzepatide trial to evaluate atrial fibrillation burden reduction post-ablation in overweight/obese patients

    This trial could establish a novel therapeutic strategy for **atrial fibrillation** management, particularly in overweight or obese patients undergoing ablation. If successful, **tirzepatide** could become a critical adjunct to standard …

  49. 2019-08-19 ClinicalTrials.gov

    Tirzepatide pharmacokinetics and tolerability compared between autoinjector and prefilled syringe delivery

    Ensuring consistent **tirzepatide** delivery across different devices is crucial for patient safety and efficacy, especially as new administration options emerge. This type of study informs regulatory approvals and device selection, impa…

  50. 2026-06-23 PubMed

    Oral HRS-7535 achieves dose-dependent weight loss up to 9.36% in obese Chinese adults

    This study provides compelling evidence that **oral HRS-7535 offers a promising, non-injectable option for obesity management**, potentially addressing a significant barrier to treatment adherence and accessibility for millions. The dose…

  51. 2026-06-23 PubMed

    GLP-1 Receptor Agonists Show Lower Hazard for Major Adverse Liver Outcomes in MASLD and Type 2 Diabetes

    This study provides crucial real-world evidence suggesting that **GLP-1 RAs may offer a therapeutic advantage for liver-specific outcomes** in patients with **MASLD** and **Type 2 Diabetes** when compared to SGLT-2 inhibitors. For clinic…

  52. 2026-06-23 PubMed

    Neuropsychological Factors Drive Vitiligo Pathogenesis via Neuro-Endocrine-Immune-Cutaneous Axis

    This review fundamentally shifts the understanding of **vitiligo** from a purely dermatological condition to one deeply intertwined with neurological and psychological factors. **Integrating neuroimmunological modulation with psychologic…

  53. 2026-06-23 PubMed

    Zebrafish GCGRa and GCGRb isoforms distinctly regulate lipid and glucose metabolism; GCGRb responds to glucagon and GLP-1.

    Zebrafish glucagon receptor isoforms, GCGRa and GCGRb, distinctly regulate lipid and glucose metabolism; GCGRb uniquely responds to both glucagon and GLP-1.

  54. 2026-06-23 PubMed

    Review Highlights Domestic Cats as Reservoirs for Antibiotic-Resistant *Staphylococcus* spp., Posing Zoonotic Threats

    The 'One Health' perspective underscores the critical need to address antibiotic resistance in companion animals, as it directly impacts human health and veterinary medicine. **This review highlights that pet owners and veterinarians mus…

  55. 2026-06-23 PubMed

    Survodutide, a Dual GLP-1/Glucagon Agonist, Improves Beta-Cell Function and Insulin Sensitivity Beyond Weight Loss

    This analysis highlights **Survodutide's** potential to offer comprehensive metabolic improvements beyond simple weight reduction, a significant advantage for individuals with **Type 2 Diabetes** and **obesity**. The finding that improve…

  56. 2026-06-23 PubMed

    LY6D drives hepatic steatosis by activating the `GRB2-AMPK-SREBP1c` axis, suggesting a novel target for **MASLD**.

    Identifying **LY6D** and its associated `GRB2-AMPK-SREBP1c` axis provides a **novel therapeutic target** for **MASLD** beyond existing GLP-1 and FXR-agonist approaches. This discovery could lead to new drug development strategies focused…

  57. 2026-06-23 PubMed

    Oral GLP-1R agonist OHP2 drives astrocyte-neuron metabolic coupling, showing neuroprotective potential in Alzheimer's disease

    This research introduces **OHP2** as a promising new candidate for **Alzheimer's disease** treatment, offering a significant advancement with its oral bioavailability and `BBB` permeability. **The discovery of OHP2's ability to modulate …

  58. 2026-06-23 PubMed

    Mitochondrial Alterations Identified as Central to Chronic Kidney Disease Pathogenesis and Emerging Therapeutic Target

    Mitochondrial alterations are increasingly recognized as central to **chronic kidney disease** pathogenesis, offering promising therapeutic targets including **SGLT2 inhibitors** and **GLP-1 receptor agonists**.

  59. 2026-06-23 PubMed

    Insulin Complexation with Curcumin Cysteine Complex (CCC) Mitigates Amyloidosis and Efficiently Manages Diabetes in Drosophila

    This research suggests a novel approach to enhance insulin stability and efficacy, directly impacting **diabetes mellitus** management. **Incorporating Curcumin Cysteine Complex (CCC) into insulin formulations could prevent aggregation a…

  60. 2026-06-23 PubMed

    Parallel Accumulation-Mobility Aligned Fragmentation (PAMAF) mass spectrometry boosts protein ID by 6x in whole cell digests.

    This advancement in mass spectrometry technology offers a significant leap for **proteomics research**, particularly in discovery workflows. The enhanced speed, sensitivity, and accuracy of `PAMAF` mode mean researchers can identify and …

  61. 2026-06-23 PubMed

    Antimicrobial Peptides Drive Rheumatoid Arthritis Pathogenesis and Offer Therapeutic Opportunities

    **Understanding the dual role of antimicrobial peptides (AMPs) in rheumatoid arthritis (RA)** opens new avenues for both diagnosis and treatment. Identifying specific AMP profiles could serve as novel biomarkers for disease activity, all…

  62. 2026-06-23 PubMed

    Pig emotional states reliably identified by ear posture, locomotor play, and cortisol changes across diverse husbandry

    **Establishing reliable, non-invasive indicators for pig emotions** provides a crucial toolkit for improving animal welfare assessments in diverse agricultural and research settings. This research offers practical, observable behavioral …

  63. 2026-06-23 PubMed

    ATR-FTIR spectroscopy with multivariate analysis effectively monitors semaglutide and liraglutide degradation and secondary structure transitions

    This study introduces a powerful, rapid, and non-destructive analytical tool that could significantly enhance the monitoring of therapeutic peptide stability. **For peptide manufacturers and formulators, this method offers a streamlined …

  64. 2026-06-23 PubMed

    Semaglutide pilot program improves glycemic control and tolerability in Cystic Fibrosis-Related Diabetes

    This pilot provides crucial **practical guidance for clinicians and diabetes educators** considering `GLP-1R` agonist therapy for **CFRD**. It suggests that **semaglutide** can be a valuable adjunct to insulin, particularly for patients …

  65. 2026-06-22 PubMed

    CD109 Drives Colorectal Cancer Stemness and Chemoresistance via LRRC8A/AKAP12/PKCα-Mediated STAT3 and WNT Signaling

    CD109 drives **colorectal cancer** stemness and chemoresistance by activating `STAT3` and `WNT` signaling through the `LRRC8A/AKAP12/PKCα` axis, making it a potential therapeutic target.

  66. 2026-06-22 PubMed

    IL-1α Blockade Sensitizes HNSCC to Photodynamic Therapy by Reversing Hypoxia and NF-κB Resistance

    This research provides a novel, clinically actionable strategy to overcome intrinsic resistance to photodynamic therapy (PDT) in **HNSCC**. **Repurposing existing clinical IL-1 inhibitors could significantly enhance PDT efficacy**, poten…

  67. 2026-06-22 PubMed

    Circulating GDF11 promotes oligodendrocyte differentiation, accelerating CNS remyelination in mouse demyelination models.

    This research identifies **GDF11 as a promising therapeutic candidate for demyelinating diseases** like **Multiple Sclerosis**. By promoting oligodendrocyte differentiation and accelerating remyelination, GDF11 could address a critical u…

  68. 2026-06-22 PubMed

    Pemafibrate significantly reduces fasting glucose, insulin, and HOMA-IR while increasing FGF21 levels.

    This meta-analysis provides strong evidence that Pemafibrate, a `PPARα` modulator, significantly improves **glucose metabolism** and **insulin sensitivity**, while also increasing `FGF21` levels. This suggests Pemafibrate could be a valu…

  69. 2026-06-22 PubMed

    Denosumab and Zoledronate Cost-Effective for Osteoporosis in Chinese Postmenopausal Women at Specific FRAX Thresholds

    This study provides crucial, real-world evidence for guiding **osteoporosis treatment decisions in China**, moving beyond generic guidelines to drug-specific, cost-effective thresholds. For clinicians and policymakers, these findings sug…

  70. 2026-06-22 PubMed

    Cladribine, cyclophosphamide, and anakinra combination induces regression in Erdheim-Chester disease, improving imaging markers.

    Cladribine, particularly in combination with cyclophosphamide, emerges as a promising second-line therapeutic option for **Erdheim-Chester disease**, especially in patients lacking `BRAF` or `MEK` mutations. **This case highlights a succ…

  71. 2026-06-22 PubMed

    Standardized Methodology Developed to Evaluate Long-Term Anti-VEGF Outcomes in Diabetic Macular Edema

    Protocol outlines standardized methodology for evaluating 24-month anti-VEGF therapy effectiveness and safety in **diabetic macular edema (DME)** using real-world data.

  72. 2026-06-22 PubMed

    Transcriptome sequencing in atherosclerotic plaques identified **CCL3**, **CCL4**, and **CXCL1** as hub chemokines linked to altered immune cell infiltration.

    **Identifying CCL3, CCL4, and CXCL1 as central hub chemokines provides novel, specific targets for developing therapies against atherosclerosis, moving beyond broad anti-inflammatory strategies that have previously underperformed.** Thes…

  73. 2026-06-22 PubMed

    M2 macrophages drive prostate cancer invasion via M-CSF-induced PCLAF upregulation

    This research identifies **PCLAF** as a crucial mediator in M2 macrophage-driven prostate cancer progression, offering a novel therapeutic target. By elucidating the **M-CSF-PCLAF** pathway, this study provides a new avenue for intervent…

  74. 2026-06-22 PubMed

    Olive Oil-Based Lipid Emulsion (OOLE) ameliorates ICI-induced myocarditis by inhibiting the NF-κB/NLRP3/IL-1β pathway

    **Olive Oil-Based Lipid Emulsion (OOLE) presents a promising adjunctive therapy for mitigating acute ICI-induced myocarditis, potentially improving outcomes for cancer patients.** This approach offers a targeted strategy to protect the h…

  75. 2026-06-22 PubMed

    NRF2 and p53 gene dysregulation, driven by oxidative stress and inflammation, linked to male infertility

    This study provides compelling evidence that the combined dysregulation of **NRF2** and **p53** is a critical factor in **male infertility**, moving beyond single-factor explanations. **Understanding these integrated pathways could lead …

  76. 2026-06-22 PubMed

    Cell-penetrating peptides and homeoproteins translocate into cells via submillisecond transient pores

    This research fundamentally redefines how **CPPs** and **HPs** enter cells, revealing a rapid, direct membrane translocation mechanism via transient pores. **Understanding this mechanism could revolutionize intracellular drug delivery st…

  77. 2026-06-22 PubMed

    Tirzepatide Modulates cAMP and Calcium Dynamics to Regulate Human Sinoatrial Node Pacemaker Function

    This research significantly expands our understanding of **Tirzepatide's** direct cardiac actions, moving beyond its established metabolic benefits. For peptide users and clinicians, this suggests that **Tirzepatide** may have direct eff…

  78. 2026-06-22 PubMed

    Epitope-Imprinted Polymers (EIPs) offer robust, selective synthetic recognition for next-generation bacterial diagnostics

    This comprehensive review clarifies the significant potential of **Epitope-Imprinted Polymers (EIPs)** to revolutionize bacterial diagnostics, offering a path towards highly selective, stable, and reproducible detection systems. For clin…

  79. 2026-06-22 PubMed

    Psoriasis and Hidradenitis Suppurativa Share Immunological Links with MASLD; GLP-1 RAs Show Therapeutic Promise

    This review significantly elevates awareness among dermatologists and clinicians regarding the profound metabolic comorbidities, particularly **MASLD**, in patients with **hidradenitis suppurativa** and **psoriasis**. **Integrating metab…

  80. 2026-06-22 PubMed

    GLP-1 Receptor Agonists Show Preclinical Neuroprotection but Inconsistent Clinical Efficacy in Parkinson's and Other Movement Disorders

    The current evidence suggests that while GLP-1RAs hold significant promise due to their robust preclinical neuroprotective effects, their clinical translation into effective treatments for movement disorders like **Parkinson's disease** …

  81. 2026-06-22 PubMed

    Review details neuro-immune crosstalk, mast cell activation, and targeted therapies for chronic spontaneous cholinergic urticaria

    **Understanding the intricate neuro-immune crosstalk in CSU-Chol opens new avenues for therapeutic intervention.** For clinicians and researchers, this review consolidates the mechanistic basis for developing more precise diagnostic tool…

  82. 2026-06-22 PubMed

    Review synthesizes Type 2 immunity's role in chronic atopic inflammation, proposing a self-amplifying cytokine cycle

    This review provides a crucial conceptual framework for understanding the chronicity of **atopic disorders**, moving beyond single-pathway explanations to a more integrated view of **Type 2 immunity** dysregulation. For researchers and c…

  83. 2026-06-22 PubMed

    Leptospira-associated acute encephalopathy driven by neuroimmune cross-talk, not direct infection

    Understanding that **Leptospira-associated AES is a neuroimmune disorder, not a direct infection**, fundamentally shifts the approach to diagnosis and treatment. For clinicians, this implies that antibiotic therapy alone may be insuffici…

  84. 2026-06-22 PubMed

    Superimposed Takotsubo and Acute MI (STAMI) Identified as Distinct Overlap Syndrome with Severe Dysfunction

    Recognition of **STAMI** is clinically paramount because the ventricular dysfunction often exceeds the expected infarct territory, significantly influencing diagnostic interpretation, risk stratification, and therapeutic management. **Th…

  85. 2026-06-22 PubMed

    Resiniferatoxin-mediated cardiac sympathetic afferent denervation improves post-MI ventricular remodeling and function in dogs

    This research highlights a novel therapeutic avenue for managing **left ventricular remodeling** after **myocardial infarction** by precisely targeting cardiac sympathetic sensory neurons. **Modulating the autonomic nervous system via CS…

  86. 2026-06-22 PubMed

    Genetic Evidence Links SGLT2i, GLP-1RA, and Metformin to Reduced Cardiovascular-Kidney-Metabolic Syndrome Risks

    Drug-target Mendelian randomization reveals genetic proxies for SGLT2i, GLP-1RA, and metformin reduce risks of CKM syndrome outcomes, while insulin and TZDs show increased risks.

  87. 2026-06-22 PubMed

    CXCL14 drives osteosarcoma cell migration and invasion by inducing epithelial-to-mesenchymal transition

    This research identifies **CXCL14 as a promising therapeutic target** for combating metastasis in osteosarcoma, a critical unmet need in pediatric bone cancer. By elucidating CXCL14's role in driving EMT via `PI3K/AKT`, `MAPK`, and `NF-κ…

  88. 2026-06-22 PubMed

    Parathyroidectomy Lowers Mortality, Cognitive Impairment, and Sepsis Risk vs. Calcimimetics in Dialysis Patients with SHPT

    This study provides compelling evidence that **parathyroidectomy (PTx)** may offer superior long-term benefits for selected dialysis patients with severe **secondary hyperparathyroidism (SHPT)**, extending beyond just bone and mineral he…

  89. 2026-06-22 PubMed

    Aryloxyphenol PA74 potentiates polymyxin B against multidrug-resistant Gram-negative bacteria and improves murine infection outcomes.

    This research introduces **PA74 as a promising adjuvant that could restore the efficacy of polymyxin B**, a critical last-resort antibiotic, against highly resistant Gram-negative pathogens. By potentiating polymyxin, PA74 may enable low…

  90. 2026-06-22 PubMed

    Colistin-sulbactam combination significantly improves microbiological eradication and clinical cure in CRAB pneumonia.

    This study provides crucial evidence supporting **colistin combined with high-dose sulbactam as a preferred therapeutic strategy for severe CRAB HAP/VAP**, especially in cases involving **XDR strains** or high bacterial burden. Clinician…

  91. 2026-06-22 PubMed

    Fibrillin-1 orchestrates pro-senescent niche, driving endothelial senescence in CKD via ZEB1/ET-1/β-catenin pathway

    This research provides a fundamental conceptual framework for **CKD**-associated vascular deterioration, identifying fibrillin-1 (FBN1) as a critical orchestrator of a pro-senescent microenvironment. **Targeting the FBN1/ZEB1/ET-1/β-cate…

  92. 2026-06-22 PubMed

    Interleukin-40 (IL-40) exacerbates allergic asthma by polarizing macrophages and impairing B cell development

    These findings position IL-40 as a critical mediator of allergic airway inflammation, offering a promising new therapeutic target for **allergic asthma**. For patients with severe or corticosteroid-refractory asthma, **targeting IL-40 co…

  93. 2026-06-22 PubMed

    WDR82 suppresses breast cancer progression by inhibiting ERK-driven chemokine expression and neutrophil infiltration

    This research uncovers a novel tumor-suppressive mechanism for WDR82 in breast cancer, highlighting its potential as a therapeutic target. **Targeting WDR82 or its downstream `ERK`-chemokine-neutrophil axis could offer a new strategy to …

  94. 2026-06-22 PubMed

    RMAD1, a novel cell-penetrating peptide, enhances cancer vaccine efficacy by boosting T cell activation and reducing tumor burden

    This study introduces **RMAD1** as a promising next-generation cell-penetrating peptide platform, offering a significant advancement for cancer vaccine development. **RMAD1's ability to enhance antigen delivery and T cell activation coul…

  95. 2026-06-22 PubMed

    USP18 drives cisplatin resistance in ovarian cancer by modulating DNA repair, a peptide inhibitor shows promise.

    This research identifies `USP18` as a novel and actionable target for overcoming **cisplatin resistance in ovarian cancer**. For clinicians and researchers, this opens a new therapeutic avenue beyond conventional chemotherapy, potentiall…

  96. 2026-06-22 PubMed

    Oral Liposome Surface Modifications Enhance Drug Bioavailability by Overcoming GI Barriers

    This review provides a critical roadmap for overcoming the significant challenges in oral drug delivery, particularly for compounds with **low bioavailability**. By detailing advanced liposome surface modification strategies, it offers p…

  97. 2026-06-22 PubMed

    Polyisocyanopeptide-based antigen-toxin conjugates selectively eliminate autoreactive B cells in RA models

    This research provides a compelling proof-of-concept for a highly targeted therapeutic approach in **rheumatoid arthritis**, moving beyond broad immunosuppression. **Developing antigen-toxin conjugates like PIC-CCP4-MMAE could enable pre…

  98. 2026-06-22 PubMed

    Jaboticaba Peel Extract Limits Castration-Resistant Prostate Cancer Aggressiveness by Counteracting EMT

    This study highlights **jaboticaba peel extract (JPE) as a promising natural adjuvant for managing castration-resistant prostate cancer (CRPC)**. By demonstrating JPE's ability to counteract **EMT** and modulate key signaling pathways li…

  99. 2026-06-22 PubMed

    Methylmalonic acid (MMA) acts as ferroptosis-derived danger signal, activating PI3K-NF-κB pathway and driving M1 macrophage polarization in renal IRI.

    This research identifies methylmalonic acid (MMA) as a novel ferroptosis-derived danger signal that directly links cellular injury to immune activation in **acute kidney injury (AKI)**. **Targeting the MMA-mediated activation of the `PI3…

  100. 2026-06-22 PubMed

    Circulating IGF-I levels linked to increased Multiple Myeloma risk in observational and genetic studies

    This research significantly strengthens the evidence for **IGF-I** as a contributing factor to **Multiple Myeloma (MM)** susceptibility, moving beyond inconsistent prior findings. The combined power of large-scale observational data and …

Go deeper on one peptide